These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening. Karlan BY; Baldwin RL; Lopez-Luevanos E; Raffel LJ; Barbuto D; Narod S; Platt LD Am J Obstet Gynecol; 1999 Apr; 180(4):917-28. PubMed ID: 10203660 [TBL] [Abstract][Full Text] [Related]
11. Genetic imbalance on chromosome 17 in papillary serous carcinoma of the peritoneum. Bandera CA; Muto MG; Welch WR; Berkowitz RS; Mok SC Oncogene; 1998 Jul; 16(26):3455-9. PubMed ID: 9692553 [TBL] [Abstract][Full Text] [Related]
12. Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome? Goshen R; Chu W; Elit L; Pal T; Hakimi J; Ackerman I; Fyles A; Mitchell M; Narod SA Gynecol Oncol; 2000 Dec; 79(3):477-81. PubMed ID: 11104623 [TBL] [Abstract][Full Text] [Related]
13. Germline mutations of the BRCA1 and BRCA2 genes in a breast and ovarian cancer patient. Randall TC; Bell KA; Rebane BA; Rubin SC; Boyd J Gynecol Oncol; 1998 Sep; 70(3):432-4. PubMed ID: 9790802 [TBL] [Abstract][Full Text] [Related]
14. High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma. Biron-Shental T; Drucker L; Altaras M; Bernheim J; Fishman A Eur J Surg Oncol; 2006 Dec; 32(10):1097-100. PubMed ID: 16650962 [TBL] [Abstract][Full Text] [Related]
15. ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum. Garrett AP; Ng SW; Muto MG; Welch WR; Bell DA; Berkowitz RS; Mok SC Gynecol Oncol; 2000 Apr; 77(1):105-11. PubMed ID: 10739698 [TBL] [Abstract][Full Text] [Related]
16. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer. Shiri-Sverdlov R; Oefner P; Green L; Baruch RG; Wagner T; Kruglikova A; Haitchick S; Hofstra RM; Papa MZ; Mulder I; Rizel S; Bar Sade RB; Dagan E; Abdeen Z; Goldman B; Friedman E Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978 [TBL] [Abstract][Full Text] [Related]
17. Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy. Schrader KA; Hurlburt J; Kalloger SE; Hansford S; Young S; Huntsman DG; Gilks CB; McAlpine JN Obstet Gynecol; 2012 Aug; 120(2 Pt 1):235-40. PubMed ID: 22776961 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum. Huang LW; Garrett AP; Muto MG; Colitti CV; Bell DA; Welch WR; Berkowitz RS; Mok SC Hum Pathol; 2000 Mar; 31(3):367-73. PubMed ID: 10746681 [TBL] [Abstract][Full Text] [Related]
19. No BRCA1 germline mutation in a family with uterine papillary serous carcinoma: a case report. Pejovic T; Koul A; Olsen D; Chambers JT Eur J Gynaecol Oncol; 2001; 22(5):336-8. PubMed ID: 11766733 [TBL] [Abstract][Full Text] [Related]
20. Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum. Schorge JO; Miller YB; Qi LJ; Muto MG; Welch WR; Berkowitz RS; Mok SC Gynecol Oncol; 2000 Mar; 76(3):369-72. PubMed ID: 10684712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]